{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01219192: Phase 1 Interventional Unknown status Pancreatic Cancer
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02796053: Phase 1/Phase 2 Interventional Completed Psoriasis Vulgaris
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01144377: Phase 2 Interventional Completed Osteoporosis
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01176461: Phase 1 Interventional Completed Melanoma (Skin)
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04612530: Phase 1 Interventional Unknown status Pancreatic Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00136526: Phase 2 Interventional Completed Prostate Cancer
(2002)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:azintuxizumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03867682: Phase 1/Phase 2 Interventional Recruiting Acute Myeloid Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03588026: Phase 3 Interventional Completed Paroxysmal Nocturnal Hemoglobinuria (PNH)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00004918: Phase 1/Phase 2 Interventional Completed Accelerated Phase Chronic Myelogenous Leukemia
(1999)
Source URL:
Class:
PROTEIN
